visit sniclinic dot com here

OUR CLIENTS

Logo
Logo
Logo
Logo
Logo
Logo
scimar logo
UNFI_white_logo

OUR EXECUTIVE TEAM

Bernie Desgagnés
Bernie Desgagnés
CEO & President
Detail
Stuart Greenfield
Stuart Greenfield
Director, Business Development
Detail
Krista Coventry, M.Sc.
Krista Coventry, M.Sc.
Senior Director, Clinical Affairs & Regulatory Strategy
Detail

LATEST BLOGS

Clinical Evidence in Skincare: Trial Design, Endpoints, and Regulatory Impact in Canada and the United States
December 11, 2025
Clinical Evidence in Skincare: Trial Design, Endpoints, and Regulatory Impact in Canada and the United States
Skincare is increasingly regulated, evidence-driven, and commercially competitive across both Canada and the United States. As brands push for stronger performance claims, broader market ac...
Veterinary Health Product Notification in Canada | VHP Guide
December 9, 2025
How to Notify a Veterinary Health Product (VHP) in Canada: Avoiding Delays, Rejections, and Costly Mistakes
Veterinary Health Products, commonly referred to as VHPs, are regulated in Canada as low-risk drugs under the Food and Drugs Act and the Food and Drug Regulations. Within this framework, VH...
Health Canada’s 2026 Proposed Updates to the Cosmetic Ingredient Hotlist: What Cosmetic Brands Need to Know
December 4, 2025
Health Canada’s 2026 Proposed Updates to the Cosmetic Ingredient Hotlist: What Cosmetic Brands Need to Know 
Health Canada has begun a new consultation on proposed revisions to the Cosmetic Ingredient Hotlist, opening the door to significant changes in how cosmetic ingredients are reviewed, classi...
Health Canada Proposes New Food Enzyme Authorization: Exo-inulinase 
December 2, 2025
Health Canada Proposes New Food Enzyme Authorization: Exo-inulinase 
On November 20th, 2025, Health Canada released a new proposal signalling its intention to authorize exo-inulinase from Trichoderma reesei strain AR 577 as a permitt...

WHAT ARE YOU WAITING FOR? GET STARTED WITH SNI TODAY!

Loading...